Pharmaceuticals

Esteve acquires TerSera Therapeutics' specialized infusion therapies business unit

The return of the E-58425 from Esteve Laboratories
1 min

Catalan pharmaceutical company Esteve and US-based TerSera Therapeutics LLC have announced an agreement under which Esteve will acquire TerSera's specialty infusion therapies (IST) business unit. This acquisition allows Esteve to expand its presence in the United States.

stats